Corticosteroid
[대역어] 코르티코스테로이드
[용어속성] Hormon
[용어속성] Hormon
Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine AZD1222
Allergy/Immunology
[키워드] acute respiratory distress
Acute respiratory failure
allergenic
allergies
allergy
Antibiotics
AstraZeneca
AZD1222
cause
ChAdOx1 nCoV-19
Corticosteroid
Corticosteroids
described
eosinophilia
eosinophilic pneumonia
eosinophils
global pandemic
Hypereosinophilia
Influenza
lack
less
male
outcome
Patient
pneumococcal
Pneumonia
polysaccharide vaccine
post-COVID-19 vaccination
postvaccination
prevented
reaction
Reactions
retained
SARS-CoV-2
vaccination
Vaccine
virus
[DOI] 10.7759/cureus.18959 PMC 바로가기 [Article Type] Allergy/Immunology
[DOI] 10.7759/cureus.18959 PMC 바로가기 [Article Type] Allergy/Immunology
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Article
[키워드] accompanied
ACE2, angiotensin-converting enzyme II
Activation
acute respiratory distress
acute respiratory syndrome
ADAM17, metalloprotease 17
alarmin
ALI, acute lung injuries
approach
AT1R, activation of angiotensin-1-receptor
BAFFR, B-cell activating factor receptor
BLC, B-lymphocyte chemoattractant
bortezomib
c-AMP, cyclic adenosine phosphate
CASP3, caspase 3
CCL, chemokine ligand
CD40+, cluster of differentiation 40
CDC, Center for Disease Control and Prevention
chemokine
coronavirus disease
Coronavirus-2
Corticosteroid
cough
CoV, coronavirus
COVID-19
COVID-19, Coronavirus disease 2019
COX-2, cyclooxygenase-2
cross-talk
CRP C, reactive protein
CTLs, cytotoxic T lymphocytes
CXCL C-X-C, motif chemokine ligand
CXCL, C-X-C- motif chemokine
cytokine
Cytokine storm
Cytokine storm syndrome
DAMP, damage-associated molecular patterns (DAMP)
demonstrated
Dexamethasone
Diseases
Dyspnoea
dysregulated
Effectiveness
Enzymes
ERK1/2, extracellular signal-regulated kinases
expression
feature
Fever
GSDMD, Gasdermin
highlight
Host
Host immune response
IKK, IκB kinase
IL-1R, Interleukin 1 receptor (IL-1R)
IL, interleukin
immune dysregulation
immune system
Inflammation
Inflammatory cytokine
inhibitor
iNOS, nitric oxide synthase
IP-10, interferon-inducible protein 10
JAK, Janus kinase
JNK, Jun amino-terminal kinases
life-threatening
LPS, lipopolysaccharides
LTβR, Lymphotoxin-β receptor
manifestation
MAPK, Mitogen-activated protein kinase
MAPKs, mitogen-activated protein kinases
MCP-1, monocyte chemoattractant protein 1
MIG, monokine induced by interferon-γ
MIP-1α and MIP-1β, macrophage inflammatory protein 1α and 1β, respectively
monoclonal antibody
morbidity and mortality
multiple organ failure
NEMO, regulatory subunit IKKγ
NF-κB
NF-κB, nuclear factor kappa B cells
NF-κB
NK, natural killer
NO, Nitric Oxide
Novel coronavirus
nucleotide
offer
PAMPs, pathogen-associated molecular patterns
pathway
PKR, threonine-derived kinases
pro-inflammatory mediators
PTMs, post-translational modifications
RANK, receptor activator of NF-κB
Remdesivir
responsible
RSV, respiratory syncytial virus
SARS-CoV-2
SARS, Severe acute respiratory syndrome
Septic shock
Severe acute respiratory syndrome
severe complication
severe COVID-19 patients
Signal transduction
significant decrease
SMD, SOD, superoxide dismutase
STAT3, signal transduction activator of transcription factor 3
STING, stimulator of interferon genes
syndrome
systemic inflammation
Th, helper T cells
therapeutic intervention
therapeutic strategy
therapy
TLR-4, Toll-like receptor-4
TNF-α
TNF, Tumour Necrosis Factor
TNFR, tumour necrosis factor receptor
tyrosine
upregulating
VEGF, Vascular endothelial growth factor
[DOI] 10.1016/j.intimp.2021.108255 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.intimp.2021.108255 PMC 바로가기 [Article Type] Article
Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study
Article
[키워드] adjusted
Admitted Patient
ARDS
Control
Corticosteroid
Corticosteroids
covariate
COVID-19
database
determine
glucocorticoid
greater
hospitals
Impact
in-hospital mortality
laboratory-confirmed
Mortality
Occurrence
Patient
patients treated
Pneumonia
reduced
remained
Respiratory failure
retrospective cohort study
SARS-CoV-2
significantly lower
Spanish
steroid
steroid treatment
subgroup of patients
Support
treated
Treatment
[DOI] 10.3390/jcm10204678 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10204678 PMC 바로가기 [Article Type] Article
Cutaneous adverse reactions after COVID ‐19 vaccines in a cohort of 2740 Italian subjects: An observational study
Observational Study
[키워드] Administered
administration
Adverse reaction
asked
characterized
Cohort
Complete
correlation
Corticosteroid
COVID
COVID‐19
COVID‐19 vaccine
Cutaneous
cutaneous adverse reaction
cutaneous manifestation
diagnosed
dose
Epidemiology
first dose
hypersensitivity
hypersensitivity reactions
incidence
individual
injection site erythema
Italian
Messenger RNA
morphology
occur
occurred
Other
Patient
patients
Prevalence
prospective observational study
questionnaire
Rash
reaction
Reactions
reported
SARS‐CoV‐2
second dose
subject
subjects
vaccination
Vaccine
[DOI] 10.1111/dth.15153 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1111/dth.15153 PMC 바로가기 [Article Type] Observational Study
Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study—The COViNEPH Project
Article
[키워드] age
analyses
analyzed
Antigen
applied
BNT162b2
booster vaccination
Chronic kidney disease
Control
Corticosteroid
COVID-19
COVID19
determinant
Efficacy
Factor
highest
humoral
IgG antibody
immune response
Immunosuppressant
immunosuppressants
immunosuppressive
independent predictor
Infection
initial
IQR
kidney transplant recipient
kidney transplant recipients
longitudinal
magnitude
median age
men
mRNA
mRNA vaccine
mRNA vaccines
mRNA-1273
mRNA-1273 vaccine
naïve
predictor
protocol
rate of seroconversion
Responder
response
response to vaccination
SARS-CoV-2 vaccination
second dose
Seroconversion
seroconversion rate
Transplant
treated
Treatment
vaccination
Vaccine
younger patient
[DOI] 10.3390/vaccines9101165 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines9101165 PMC 바로가기 [Article Type] Article
Challenges in Steroid and Anticoagulant Therapy in Severe COVID-19 Pneumonia: A Prospective Study
Article
[키워드] acute kidney
adopted
Anti-inflammatory
Anticoagulant
assessment
Assiut University Hospital
bleeding
C reactive protein
challenge
Clinical outcome
comorbid diseases
Complication
conducted
Corticosteroid
Corticosteroids
COVID-19
COVID-19 patient
D-dimer
discharge
disease
enoxaparin
ferritin
flexible
Follow-up
group
hematoma
highest
hospital
Hospital stay
ICU
In-hospital
lowest
Lung fibrosis
Methylprednisolone
mortality rate
multivariable
Myocardial infarction
outcome
Oxygen therapy
Patient
patient group
patients
predictor
Prospective
protocol
RT-PCR
severe COVID-19 patient
Severe COVID-19 pneumonia
severe pneumonia
significant difference
standard treatment
steroid
Study design
therapeutic
therapy
three group
Treatment
Treatment protocol
two groups
was performed
[DOI] 10.3390/antibiotics10101214 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/antibiotics10101214 PMC 바로가기 [Article Type] Article
SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway
SARS-CoV-2는 DUSP1 발현을 억제하고 p38 MAPK 경로를 활성화하여 코르티코스테로이드 감수성을 약화시킵니다
Observational Study
[키워드] activating
Activation
attenuate
Chloroquine
Corticosteroid
Corticosteroids
COVID-19
data set
data sets
downregulate
downregulation
DUSP1
Efficacy
expected
expression
IMPROVE
in vitro experiments
induce
lung tissue
MAPK
mechanism
nasopharyngeal swabs
p38 MAPK pathway.
pathway
reported
required
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
sensitivity
significantly
steroid
steroid treatment
Treatment
[DOI] 10.1016/j.ejphar.2021.174374 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.ejphar.2021.174374 PMC 바로가기 [Article Type] Observational Study
Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia
삽관하지 않은 중증 코로나19 폐렴 환자에서 혈청 페리틴 수치와 메틸프레드니솔론 치료의 결과와의 연관성
Research
[키워드] 95% CI
acute phase
Administered
Admission
age
Analysis
analyzed
Asian
association
baseline
benefit
Biomarker
Black patient
Clinical outcome
cohort study
Composite
Corticosteroid
COVID-19
daily dose
death
Effectiveness
end point
exposure
ferritin
ferritin level
finding
fraction
functions
high-flow oxygen therapy
Importance
Inflammation
Laboratory
Level
lower mortality
marker
measure
mechanical ventilation
median
Methylprednisolone
Mortality
New York
objective
outcome
oxidative stress
oxygen
participant
Patient
Point
Primary outcome
Probability
Protein
receiving
reduced
Relevance
reported
Result
retrospective cohort study
secondary outcome
Serum ferritin
serum ferritin level
setting
severe COVID-19
Severe COVID-19 pneumonia
systemic
Treatment
Treatment outcome
treatment with methylprednisolone
variables
White patient
[DOI] 10.1001/jamanetworkopen.2021.27172 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2021.27172 PMC 바로가기 [Article Type] Research
Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient
리툭시맙 치료 다발성 경화증 환자에서 COVID-19 백신 접종 후 급성 재발 및 불량한 면역
Case Reports
[키워드] Adenovirus
adenovirus-based
adhere
adverse event
anti-CD20
anti-SARS-CoV-2
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
assessments
Ataxia
Autoimmune disease
Autoimmune diseases
Awareness
cerebellar peduncle
clinical trial
clinician
Corticosteroid
corticosteroid therapy
COVID-19
COVID-19 vaccination
COVID-19 vaccine
COVID-19 vaccines
decision
Detection limit
develop
diagnosed
dose
Efficacy
fatigue
first dose
FIVE
Gam-COVID-Vac
Immunity
immunization
lesions
magnetic resonance imaging
Mild symptom
mild symptoms
monoclonal antibody
multiple sclerosis
myalgia
Neurological deficit
neurological deficits
oral steroid
Patient
Phase I
raise
receive
receiving
right hemiplegia
risk
rituximab
SARS-CoV-2
steroid
subpopulations
the patient
the vaccine
treated
Treatment
vaccination schedule
Vaccine
Vaccines
weakness
[DOI] 10.1080/21645515.2021.1928463 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1080/21645515.2021.1928463 PMC 바로가기 [Article Type] Case Reports